Getinge AB (publ) (GNGBF)
USD 21.11
(4.4%)
USD 21.11
(4.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 5.34 Billion SEK | 3513.51% |
| 2022 | 148 Million SEK | -35.65% |
| 2021 | 230 Million SEK | -94.46% |
| 2020 | 4.15 Billion SEK | -52.66% |
| 2019 | 8.76 Billion SEK | -8.27% |
| 2018 | 9.55 Billion SEK | -1.6% |
| 2017 | 9.71 Billion SEK | -51.5% |
| 2016 | 20.02 Billion SEK | 1.04% |
| 2015 | 19.81 Billion SEK | 2.83% |
| 2014 | 19.26 Billion SEK | 20.27% |
| 2013 | 16.02 Billion SEK | -1.54% |
| 2012 | 16.27 Billion SEK | 5.1% |
| 2011 | 15.48 Billion SEK | 33.89% |
| 2010 | 11.56 Billion SEK | -21.14% |
| 2009 | 14.66 Billion SEK | 25.93% |
| 2008 | 11.64 Billion SEK | 39.97% |
| 2007 | 8.31 Billion SEK | 122.14% |
| 2006 | 3.74 Billion SEK | 9.33% |
| 2005 | 3.42 Billion SEK | 6.6% |
| 2004 | 3.21 Billion SEK | 17.24% |
| 2003 | 2.74 Billion SEK | 36.87% |
| 2002 | 2 Billion SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 6.32 Billion SEK | 27.19% |
| 2024 Q3 | 6.89 Billion SEK | 36.4% |
| 2024 Q1 | 4.97 Billion SEK | -7.01% |
| 2023 Q4 | 5.34 Billion SEK | 262.09% |
| 2023 Q1 | 1.19 Billion SEK | 704.73% |
| 2023 Q2 | 2.45 Billion SEK | 106.47% |
| 2023 Q3 | 1.47 Billion SEK | -39.93% |
| 2023 FY | 5.34 Billion SEK | 3513.51% |
| 2022 Q4 | 148 Million SEK | -77.58% |
| 2022 Q2 | 1.24 Billion SEK | 4382.76% |
| 2022 Q1 | -29 Million SEK | -112.61% |
| 2022 Q3 | 660 Million SEK | -46.86% |
| 2022 FY | 148 Million SEK | -35.65% |
| 2021 Q2 | 2.04 Billion SEK | -14.64% |
| 2021 FY | 230 Million SEK | -94.46% |
| 2021 Q4 | 230 Million SEK | -74.47% |
| 2021 Q3 | 901 Million SEK | -55.83% |
| 2021 Q1 | 2.39 Billion SEK | -42.41% |
| 2020 Q4 | 4.15 Billion SEK | -34.34% |
| 2020 FY | 4.15 Billion SEK | -52.66% |
| 2020 Q1 | 9.12 Billion SEK | 4.07% |
| 2020 Q2 | 7.43 Billion SEK | -18.54% |
| 2020 Q3 | 6.32 Billion SEK | -14.96% |
| 2019 Q3 | 10.37 Billion SEK | -1.51% |
| 2019 Q2 | 10.53 Billion SEK | -1.5% |
| 2019 FY | 8.76 Billion SEK | -8.27% |
| 2019 Q1 | 10.69 Billion SEK | 11.95% |
| 2019 Q4 | 8.76 Billion SEK | -15.53% |
| 2018 Q2 | 10.62 Billion SEK | 7.21% |
| 2018 Q4 | 9.55 Billion SEK | -2.41% |
| 2018 FY | 9.55 Billion SEK | -1.6% |
| 2018 Q3 | 9.79 Billion SEK | -7.82% |
| 2018 Q1 | 9.9 Billion SEK | 2.04% |
| 2017 FY | 9.71 Billion SEK | -51.5% |
| 2017 Q1 | 19.39 Billion SEK | -3.13% |
| 2017 Q3 | 14.62 Billion SEK | -24.98% |
| 2017 Q2 | 19.49 Billion SEK | 0.53% |
| 2017 Q4 | 9.71 Billion SEK | -33.61% |
| 2016 Q4 | 20.02 Billion SEK | -0.48% |
| 2016 FY | 20.02 Billion SEK | 1.04% |
| 2016 Q3 | 20.11 Billion SEK | -0.54% |
| 2016 Q2 | 20.22 Billion SEK | 2.81% |
| 2016 Q1 | 19.67 Billion SEK | -0.71% |
| 2015 Q4 | 19.81 Billion SEK | -2.65% |
| 2015 FY | 19.81 Billion SEK | 2.83% |
| 2015 Q3 | 20.35 Billion SEK | 0.76% |
| 2015 Q2 | 20.2 Billion SEK | -0.24% |
| 2015 Q1 | 20.25 Billion SEK | 5.09% |
| 2014 Q2 | 18.03 Billion SEK | 19.8% |
| 2014 Q3 | 18.93 Billion SEK | 5.01% |
| 2014 Q4 | 19.26 Billion SEK | 1.77% |
| 2014 Q1 | 15.05 Billion SEK | -6.06% |
| 2014 FY | 19.26 Billion SEK | 20.27% |
| 2013 Q2 | 17.55 Billion SEK | 1732.56% |
| 2013 Q1 | -1.07 Billion SEK | -106.61% |
| 2013 Q4 | 16.02 Billion SEK | 6.89% |
| 2013 FY | 16.02 Billion SEK | -1.54% |
| 2013 Q3 | 14.98 Billion SEK | -14.6% |
| 2012 Q2 | -1.21 Billion SEK | -7.78% |
| 2012 Q4 | 16.27 Billion SEK | 1268.89% |
| 2012 FY | 16.27 Billion SEK | 5.1% |
| 2012 Q1 | -1.13 Billion SEK | -107.31% |
| 2012 Q3 | -1.39 Billion SEK | -14.19% |
| 2011 FY | 15.48 Billion SEK | 33.89% |
| 2011 Q4 | 15.48 Billion SEK | 1524.29% |
| 2011 Q3 | -1.08 Billion SEK | -5.53% |
| 2011 Q2 | -1.03 Billion SEK | -0.39% |
| 2011 Q1 | -1.02 Billion SEK | -108.87% |
| 2010 Q1 | -1.25 Billion SEK | -108.58% |
| 2010 Q2 | -1.37 Billion SEK | -8.98% |
| 2010 Q4 | 11.56 Billion SEK | 1055.62% |
| 2010 Q3 | -1.21 Billion SEK | 11.74% |
| 2010 FY | 11.56 Billion SEK | -21.14% |
| 2009 Q4 | 14.66 Billion SEK | 0.0% |
| 2009 FY | 14.66 Billion SEK | 25.93% |
| 2008 FY | 11.64 Billion SEK | 39.97% |
| 2007 FY | 8.31 Billion SEK | 122.14% |
| 2006 FY | 3.74 Billion SEK | 9.33% |
| 2005 FY | 3.42 Billion SEK | 6.6% |
| 2004 FY | 3.21 Billion SEK | 17.24% |
| 2003 FY | 2.74 Billion SEK | 36.87% |
| 2002 FY | 2 Billion SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| IR-Med Inc. | -606 Thousand USD | 882608.251% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 14.82 Million USD | -35970.423% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -2468876.215% |
| Polarean Imaging plc | -5.94 Million USD | 90034.712% |
| Avitar, Inc. | 5.17 Million USD | -103319.796% |
| AVITA Medical, Inc. | -26.23 Million USD | 20487.612% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 76400100.0% |
| Össur hf. | 395.08 Million USD | -1253.65% |
| Zecotek Photonics Inc. | 2.76 Million USD | -193496.264% |
| QHSLab, Inc. | 1.72 Million USD | -309038.309% |
| Wellstar International, Inc. | 51.36 Million USD | -10311.366% |
| Össur hf. | 395.08 Million USD | -1253.65% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 115928.502% |
| Escalon Medical Corp. | 315.68 Thousand USD | -1693988.43% |
| Aurora Spine Corporation | 1.9 Million USD | -280244.192% |
| BrainsWay Ltd. | -10.32 Million USD | 51921.705% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | -221346.891% |
| Hamilton Thorne Ltd. | 18.12 Million USD | -29404.512% |
| Vivos Inc. | -1.59 Million USD | 335969.099% |
| MicroPort Scientific Corporation | 673.58 Million USD | -693.964% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -1097301.571% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 988665.323% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -835267.863% |
| Nanomix Corporation | 11.38 Million USD | -46856.943% |
| Theraclion SA | -5.86 Million EUR | 91292.226% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | -134086.998% |
| Positron Corporation | 1.68 Million USD | -316935.0% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -331900.283% |
| Lombard Medical, Inc. | 11.49 Million USD | -46424.576% |
| ALR Technologies Inc. | 19.14 Million USD | -27829.453% |
| Stratec SE | 119.12 Million USD | -4389.426% |
| Vycor Medical, Inc. | 1.05 Million USD | -507802.982% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -9724420.411% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -5738466.861% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 38889.371% |
| SANUWAVE Health, Inc. | 30.14 Million USD | -17639.742% |
| VMS Rehab Systems, Inc. | 133.52 USD | -4005392350.569% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -364453.759% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -847552.393% |
| Odyssey Group International, Inc. | 2.1 Million USD | -253624.864% |
| United American Healthcare Corporation | -9.32 Million USD | 57438.909% |
| ECGI Holdings, Inc. | 3.17 Million USD | -168540.498% |
| Capital Group Holdings, Inc. | -3508.00 USD | 152451639.339% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -2036317.915% |
| Urologix, Inc. | 4.61 Million USD | -115782.99% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | -126948.291% |
| Nexeon MedSystems Inc. | 3.33 Million USD | -160440.482% |
| SS Innovations International, Inc. | 1.18 Million USD | -451076.662% |
| Qualis Innovations, Inc. | 6671.00 USD | -80167790.871% |
| Smith & Nephew plc | 2.77 Billion USD | -92.508% |
| NIOX Group Plc | -23.93 Million USD | 22446.275% |
| Fuse Medical, Inc. | 1.75 Million USD | -304543.42% |
| Broncus Holding Corporation | -81.42 Million USD | 6668.015% |
| Brain Scientific Inc. | 2.11 Million USD | -252668.376% |
| Pressure BioSciences, Inc. | 22.67 Million USD | -23483.275% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -13519631.021% |